PL2125004T3 - Synergiczne zastosowanie terapeutyczne koncentratów czynników zespołu protrombiny z koncentratami FVIII - Google Patents

Synergiczne zastosowanie terapeutyczne koncentratów czynników zespołu protrombiny z koncentratami FVIII

Info

Publication number
PL2125004T3
PL2125004T3 PL07856831T PL07856831T PL2125004T3 PL 2125004 T3 PL2125004 T3 PL 2125004T3 PL 07856831 T PL07856831 T PL 07856831T PL 07856831 T PL07856831 T PL 07856831T PL 2125004 T3 PL2125004 T3 PL 2125004T3
Authority
PL
Poland
Prior art keywords
concentrates
therapeutic use
fviii
synergistic therapeutic
prothrombin complex
Prior art date
Application number
PL07856831T
Other languages
English (en)
Inventor
Gerhard Dickneite
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of PL2125004T3 publication Critical patent/PL2125004T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL07856831T 2006-12-22 2007-12-18 Synergiczne zastosowanie terapeutyczne koncentratów czynników zespołu protrombiny z koncentratami FVIII PL2125004T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06026748A EP1935429A1 (en) 2006-12-22 2006-12-22 Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
PCT/EP2007/011099 WO2008077529A1 (en) 2006-12-22 2007-12-18 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates
EP07856831.8A EP2125004B1 (en) 2006-12-22 2007-12-18 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates

Publications (1)

Publication Number Publication Date
PL2125004T3 true PL2125004T3 (pl) 2020-08-24

Family

ID=38137453

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07856831T PL2125004T3 (pl) 2006-12-22 2007-12-18 Synergiczne zastosowanie terapeutyczne koncentratów czynników zespołu protrombiny z koncentratami FVIII

Country Status (10)

Country Link
US (2) US8394768B2 (pl)
EP (2) EP1935429A1 (pl)
JP (1) JP5331704B2 (pl)
KR (1) KR101567762B1 (pl)
AU (1) AU2007338385B2 (pl)
CA (1) CA2673446C (pl)
DK (1) DK2125004T3 (pl)
ES (1) ES2788075T3 (pl)
PL (1) PL2125004T3 (pl)
WO (1) WO2008077529A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1935429A1 (en) * 2006-12-22 2008-06-25 CSL Behring GmbH Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
MX343784B (es) 2010-10-06 2016-11-23 Medimmune Ltd Factor ii y fibrinogeno para tratamiento de trastornos hemostaticos.
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
WO2013083858A1 (en) 2012-04-24 2013-06-13 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
US10231993B2 (en) 2013-06-27 2019-03-19 University Of Washington Through Its Center For Commercialization Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
CN103933404A (zh) * 2014-05-08 2014-07-23 陈艳 一种治疗产后恶露不尽的中药制剂
EP3175245B1 (en) * 2014-07-31 2019-05-29 Haemonetics Corporation Detection and classification of an anticoagulant using a clotting assay
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2016161422A1 (en) * 2015-04-02 2016-10-06 Kieu Hoang A method of manufacturing and purifiying prothrombin complex concentrate from fraction iii for intraveneous injection and a method of curing and preventing hemophilia a with inhibitors or hempophilia b patients infected with hiv-1 and hiv-2
AU2016248817A1 (en) * 2015-04-17 2017-08-17 F. Hoffmann-La Roche Ag Combination therapy with coagulation factors and multispecific antibodies
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247150A1 (de) * 1982-12-21 1984-06-28 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems
US5543502A (en) * 1986-06-24 1996-08-06 Novo Nordisk A/S Process for producing a coagulation active complex of factor VIII fragments
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
US5493187A (en) * 1993-05-18 1996-02-20 Yamamoto Electric Corporation Method and apparatus for controlling brushless motor
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
DE4430205A1 (de) 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4444045C2 (de) * 1994-12-10 1997-04-17 Behringwerke Ag Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten
HUP9700603A3 (en) 1996-03-20 2001-08-28 Baxter Ag Pharmaceutical preparation for the treatment of blood coagulation disorders
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
EP1935429A1 (en) * 2006-12-22 2008-06-25 CSL Behring GmbH Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates

Also Published As

Publication number Publication date
AU2007338385B2 (en) 2013-10-03
US8580737B2 (en) 2013-11-12
JP5331704B2 (ja) 2013-10-30
WO2008077529A1 (en) 2008-07-03
EP2125004B1 (en) 2020-03-18
JP2010513349A (ja) 2010-04-30
AU2007338385A1 (en) 2008-07-03
US20130005657A1 (en) 2013-01-03
KR101567762B1 (ko) 2015-11-11
KR20090092325A (ko) 2009-08-31
US8394768B2 (en) 2013-03-12
EP2125004A1 (en) 2009-12-02
US20100093607A1 (en) 2010-04-15
DK2125004T3 (da) 2020-06-15
CA2673446A1 (en) 2008-07-03
ES2788075T3 (es) 2020-10-20
CA2673446C (en) 2016-06-14
EP1935429A1 (en) 2008-06-25

Similar Documents

Publication Publication Date Title
DK2125004T3 (da) Synergistisk terapeutisk anvendelse af prothrombinkompleks koncentrater med fviii koncentrater
IL249941A0 (en) Spiro-oxaindole substances and medical preparations containing them
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
HUE037639T2 (hu) Pimavanszerin együttes beadása más szerekkel
GB0609492D0 (en) Therapeutic agents
GB0625659D0 (en) Therapeutic compounds and their use
IL186616A0 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
IL201235A0 (en) Therapeutic agents
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
SI3222615T1 (sl) Sredstva za vezavo na PSMA in uporabe le-teh
GB0723747D0 (en) Therapeutic agents
GB0616214D0 (en) Therapeutic Agents
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
GB0620059D0 (en) Therapeutic agents
EP2231163A4 (en) COMPOUNDS AND THEIR THERAPEUTIC USE
GB0609676D0 (en) Therapeutic agents
GB0723748D0 (en) Therapeutic agents
GB0622195D0 (en) Therapeutic agents
GB0711465D0 (en) Silan-3-amines and disilan-5-amines as therapeutic agents
GB0614538D0 (en) Therapeutic Compounds And Their Use
GB0620062D0 (en) Therapeutic agents
GB0612644D0 (en) Therapeutic agents